Gathering the Tools for a Renewed UCSF Department of Radiation Oncology: From Dose to Image to Dose

pouliot
SPEAKER:
JEAN POULIOT
DATE/TIME:
MON, 09/26/2011 - 4:00PM TO 5:00PM
LOCATION:
3105 ETCHEVERRY HALL
Fall 2011 Colloquium Series
Abstract:

Radiation therapy, alone or in combination with other modalities, is involved in the treatment of a majority of cancers, is practiced in every clinic and used to treat practically every site of the body. The field of radiation oncology is a perfect example of a multidisciplinary environment requiring expertise of people from widely different backgrounds. In order to control the tumor and cure the cancer patient, one needs to deliver a high dose to cancer cells, drawing on concepts related to radiation, energy, radiobiology, imaging, computation and statistics. By understanding those concepts, the medical physicist plays a key role and allows the team members to safely and effectively use radiation in the treatment of cancer.

Recent advances in treatment delivery that improve conformality of dose to the tumor volume have the potential to benefit a great number of patients. At the same time, additional precision in treatment delivery becomes of utmost importance due to the high dose gradients placed near sensitive structures. Fuelled by increasingly sophisticated imaging capabilities in the treatment room, many departments of radiation oncology are pursuing Adaptive Radiation Therapy strategies that seek to improve patient dose distributions by introducing feedback into the treatment process.

At UCSF, the department of radiation oncology is undergoing a major technological upgrade driven by the fact that each cancer is unique. One needs to be able to choose among a variety of technologies and radiation devices that are best adapted to each patient need. Most importantly, we need to use this technology appropriately. After briefly introducing the field of radiation oncology, the presentation will describe some of the concepts, technologies and research orientations pursued in our department. A special emphasis will be placed on the increasing role of imaging at each step of radiation therapy.

About the Speaker:

Jean Pouliot received his Ph.D. degree in Physics from Laval University, Quebec in 1986, performed his postdoctoral fellow at Lawrence Berkeley Laboratory in heavy-ion nuclear physics and joined the Medical Physics field in 1993. He is currently Director of the Medical Physics Division, Vice Chair and Professor of Radiation Oncology with the University of California, San Francisco with a joint appointment with the Graduate Bioengineering UC-Berkeley UCSF program. His current main thrusts of research interest are on the development and the clinical integration of Dose-Guided Radiation Therapy with Megavoltage Cone-Beam CT for patient verification, organ motion and tumor evolution studies during cancer irradiation, and on an Inverse Planning (IPSA) for the dose distribution optimization of image-guided High Dose-Rate and Permanent Prostate Implant Brachytherapy. Author and co-author of more than 160 peer-reviewed publications, Dr Pouliot was voted among the Top 25 Innovators in U.S., Health Imaging and IT, in June 2006 for his pioneering research on MegaVoltage Cone Beam CT imaging.

The Materials Test Station: A Fast Spectrum Irradiation Facility

Eric_Pitcher
SPEAKER:
ERIC PITCHER
DATE/TIME:
MON, 09/19/2011 - 4:00PM TO 5:00PM
LOCATION:
3105 ETCHEVERRY HALL
Fall 2011 Colloquium Series
Abstract:

The proposed Materials Test Station, to be built at the Los Alamos Neutron Science Center, will use the high-power proton beam from the LANSCE accelerator to create an intense neutron irradiation environment for nuclear materials testing. The primary mission is to test advanced fuels and materials for fast reactor applications, including fuels bearing minor actinides, in support of the DOE Office of Nuclear Energy's Fuel Cycle R&D program. Damage rates of up to 15 dpa per year in iron can be achieved within the fuel irradiation region. Not only can the MTS perform integral testing of fuel rodlets subjected to prototypic fast reactor conditions, it is also well suited to conducting separate effects experiments that are critically important to understanding the underlying processes that contribute to fuel aging and ultimately fuel failure. Separate effects testing of the type than can be conducted in MTS can validate modeling efforts that are used to simulate fuel performance.

About the Speaker:

Eric Pitcher earned his Ph.D. in nuclear engineering from the University of Michigan in 1992. He has been employed at Los Alamos National Laboratory since 1982, having started with the Undergraduate Student program. He converted from a postdoctoral position to a staff member in 1993. His technical area of expertise is spallation neutron source design, with an emphasis on modeling source performance using Monte Carlo radiation transport codes. In 2004, he was named the Deputy Group Leader (and later Acting Group Leader) of the Nuclear Physics group within the Lab’s Theoretical Division, and in 2005 he assumed his current position as Manager of the Materials Test Station project. He is an active member of the American Nuclear Society’s Accelerator Applications Division, having served on its Executive Committee for five years, including one year as the Chair (2007–2008). In 2004, he participated in an IAEA Specialist’s Meeting on the technology and use of low-energy accelerator-driven neutron sources. He has served on a number of review committees, including a “Temple Review” of the Oak Ridge National Laboratory’s Spallation Neutron Source target station in 1999 and Michigan State University’s Facility for Radioactive Ion Beams target station in 2010. He has authored or co-authored over 20 journal articles and more than 80 papers in conference proceedings.

Video:

Research Opportunities at LBNL in Accelerator-Based Future Light Sources and Ion Beam Cancer Therapy

David_Robin
SPEAKER:
DAVID ROBIN
DATE/TIME:
MON, 09/12/2011 - 4:00PM TO 5:00PM
LOCATION:
3105 ETCHEVERRY HALL
Fall 2011 Colloquium Series
Abstract:

At Lawrence Berkeley National Laboratory (LBNL) there is a long and distinguished history in the development of accelerator-based synchrotron light and ion beam cancer therapy (IBCT) facilities. LBNL built and commissioned the Advanced Light Source (ALS), the world’s first soft X-ray third generation light source in early 1990s, that is currently the world’s brightest source of soft X-rays. In addition to the ALS, extensive work is underway directed at the development of the next generation of Free Electron Lasers (FELs). With the success of the ALS and the consolidated FEL R&D activities, LBNL is well positioned to host a soft X-ray FEL of unprecedented brightness. In the area of ion beam cancer therapy, LBNL also has a distinguished history. The field of IBCT was pioneered at LBNL in the 1950s. In subsequent years, 4,000 patients were treated using protons or heavier ions such as carbon. Worldwide IBCT is currently a rapidly expanding field with nearly 100,000 patients having been treated. Presently at LBNL, R&D is underway to develop technologies to improve ion beam cancer therapy that might significantly improve the performance or reduce the cost of treatment. In this talk, Dr. Robin will briefly describe the present research activities, and future prospects in light sources and ion beam cancer therapy.

About the Speaker:

David Robin is an accelerator physicist and senior scientist at Lawrence Berkeley National Laboratory (LBNL). He joined LBNL after completing his Ph.D. thesis at University of California, Los Angeles (UCLA) in 1991 on quasi-isochronous storage ring accelerators under the direction of Professor Claudio Pellegrini. After joining LBNL, he initially worked on the lattice design and beam dynamics for the SLAC PEP-II B-Factory's Low Energy Ring. In 1993, he joined the staff of the Advanced Light Source located at LBNL. The Advanced Light Source is a synchrotron radiation source optimized to generate soft X-ray radiation and is currently the world's brightest source of soft X-ray radiation. At the Advanced Light Source he has led many upgrades of the accelerator including the Superbend and the Top-off upgrades. His current position is Division Deputy for Accelerator Operations and Development at the Advanced Light Source where he oversees upgrades and development of the accelerators. More recently he has been involved in the design and development of an ultra high brightness soft x-ray free electron laser. Also he has been involved in an effort to explore how LBNL can now contribute technology to the field of Ion Beam Cancer Therapy (IBCT) and help to bring a world leading IBCT center to the Bay Area – where the field of Ion Beam Therapy began.